Filing Flows › CVS Health (CVS) › Guidance & outlook
CVS Health (CVS) guidance and outlook
CVS Health (CVS) raised its guidance on Nov 4, 2026: EPS $6.98 for FY2026; EPS $8.20 for FY2026; Operating cash flow $15.5B for FY2026; Revenue $4.0M for FY2026. CVS Health's 10-Q filed Nov 4, 2026 makes 10 forward-looking statements, 1 of them new and 0 no longer said since the filing before.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | $6.98 | raised |
| EPS | FY2026 | $8.20 | raised |
| Operating cash flow | FY2026 | $15.5B | raised |
| Revenue | FY2026 | $4.0M | new |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 4, 2026
- Although the level of utilization is difficult to accurately predict, utilization beyond current elevated levels may pressure the Company’s Health Care Benefits segment and its health care delivery assets in its Health Services segment in 2026.
- In addition, marketplace dynamics and regulatory changes have limited the Company’s ability to offer plan sponsors pricing that includes retail network “differential” or “spread.” The Company expects these trends to continue.
- Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results.
- Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results.
- new · The Company’s 2027 star ratings will be used to determine which of the Company’s Medicare Advantage plans have
- Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results.
- Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results.
- The outlook on the Company’s long-term debt is “Negative” by Fitch and “Stable” by S&P.
- In August 2026, Moody’s changed its outlook on the Company’s long-term debt from “Stable” to “Positive”.
- Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot predict the future actions of Fitch, Moody’s and/or S&P.
CVS Health's latest quarter
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart follows the revenue to costs, profit and cash.
Questions
Did CVS Health raise or lower its guidance?
CVS Health (CVS) raised its guidance on Nov 4, 2026: EPS $6.98 for FY2026; EPS $8.20 for FY2026; Operating cash flow $15.5B for FY2026; Revenue $4.0M for FY2026.
What does CVS Health expect?
The Company’s 2027 star ratings will be used to determine which of the Company’s Medicare Advantage plans have
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.